De Lisle Partners’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,510
| Closed | -$902K | – | 188 |
|
|
2025
Q1 | $902K | Hold |
81,510
| – | – | 0.15% | 145 |
|
|
2024
Q4 | $868K | Hold |
81,510
| – | – | 0.13% | 152 |
|
|
2024
Q3 | $1.04M | Hold |
81,510
| – | – | 0.17% | 139 |
|
|
2024
Q2 | $1.37M | Buy |
81,510
+4,417
| +6% | +$74.2K | 0.3% | 89 |
|
|
2024
Q1 | $1.15M | Buy |
+77,093
| New | +$1.15M | 0.27% | 98 |
|